ReviewOncotarget2016

Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients.

Bo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.